Titel

Merkliste
1 Ergebnisse

Supplementary Table S5 from Phase II Study of Durvalumab Im..:

Shinji Nakamichi ; Kaoru Kubota ; Toshihiro Misumi...
https://figshare.com/articles/journal_contribution/Supplementary_Table_S5_from_Phase_II_Study_of_Durvalumab_Immediately_after_Completion_of_Chemoradiotherapy_in_Unresectable_Stage_III_Non_small_Cell_Lung_Cancer_TORG1937_DATE_Study_/25415543. , 2024

Link: https://doi.org/10.1158/1078-0432.25415543.v1

RT Journal
T1 <Title>Supplementary Table S5 from Phase II Study of Durvalumab Immediately after Completion of Chemoradiotherapy in Unresectable Stage III Non–small Cell Lung Cancer: TORG1937 (DATE Study)</Title>

UL https://suche.suub.uni-bremen.de/peid=base-ftsmithonianinsp:oai:figshare.com:article_25415543&Exemplar=1&LAN=DE
				
A1 Shinji Nakamichi
A1 Kaoru Kubota
A1 Toshihiro Misumi
A1 Tetsuro Kondo
A1 Shuji Murakami
A1 Yoshimasa Shiraishi
A1 Hisao Imai
A1 Daijiro Harada
A1 Kazutoshi Isobe
A1 Hidetoshi Itani
A1 Saori Takata
A1 Hiroshi Wakui
A1 Yuki Misumi
A1 Satoshi Ikeda
A1 Tetsuhiko Asao
A1 Naoki Furuya
A1 Shinobu Hosokawa
A1 Yumiko Kobayashi
A1 Yuichi Takiguchi
A1 Hiroaki Okamoto
YR 2024
K1 Cancer
K1 Immuno-oncology
K1 Clinical Research and Trials
K1 Clinical Trial Results
K1 Phase II clinical trials
K1 Immunotherapy
K1 Checkpoint blockade
K1 Lung Cancer
JF https://figshare.com/articles/journal_contribution/Supplementary_Table_S5_from_Phase_II_Study_of_Durvalumab_Immediately_after_Completion_of_Chemoradiotherapy_in_Unresectable_Stage_III_Non_small_Cell_Lung_Cancer_TORG1937_DATE_Study_/25415543
LK http://dx.doi.org/https://doi.org/10.1158/1078-0432.25415543.v1
DO https://doi.org/10.1158/1078-0432.25415543.v1
SF ELIB - SuUB Bremen

Export

RefWorks (nur Desktop-Version!)
Flow (Zuerst in Flow einloggen, dann importieren)